Jack Cary Eichenbaum Summer Scholars Program | NYU Langone Health

Skip to Main Content
Neonatology Medical Student Education Jack Cary Eichenbaum Summer Scholars Program

Jack Cary Eichenbaum Summer Scholars Program

The Jack Cary Eichenbaum Summer Scholars Program in NYU Langone’s Division of Neonatology started in 1999 and provides medical and premedical students from across the country a unique opportunity to participate in neonatology research projects and clinical and observational rotations. The goal of the eight-week program is to foster and encourage students’ interest in the importance of medical research and provide an introduction to the medical profession by allowing them to explore various areas of pediatrics and neonatology.

Through the program, students are paired with a physician and a neonatal–perinatal fellow who mentor them to perform basic or clinical neonatology research. Many of these projects are used in future publications, and more than 95 percent of the scholars pursue careers in medicine and healthcare. The program also provides an introduction to patient care and ethical issues in neonatal medicine and offers various events for networking and professional growth.

The program directors are Pradeep N. Mally, MD, and Sean M. Bailey, MD. For more information, contact Lauren Paletti, division administrator, at lauren.paletti@nyulangone.org or 212-263-7950.

Jack Cary Eichenbaum Summer Scholars Program Application

The Jack Cary Eichenbaum Summer Scholars Program is open to medical and premedical students. Premedical students must be in good standing at a university. Preference is given to students who are entering their third or fourth year. The program is no longer accepting applications from high school students.

We appreciate your interest in our program. Our 2021 program has been canceled but we look forward to hosting our program in the summer of 2022. The application period for the 2022 program is from December 15, 2021, to February 15, 2022. Please check back for additional information at that time, including the application. Our tentative 2022 program dates are June 16, 2022, to August 12, 2022.

Past Scholar Projects

The following research projects were conducted in 2017–19.

Retrospective Review on the Implementation and Outcomes of a Dextrose Gel Protocol for the Treatment of Transient Neonatal Hypoglycemia

By Priyanshi Jain, Kayla Rebetti, and Marissa Rice (2019)

The primary objective is to assess whether there was a change in intravenous fluid (IVF) administration rates after implementation of the institution’s dextrose gel protocol. The secondary outcomes include assessing a change in neonatal intensive care unit admission rates and incidence of hyperglycemia between the utilization of weight-based dosing to standardized dosing of dextrose gel, variations in efficacy of dextrose gel based on hypoglycemia risk factors, and difference in rates of discharge home from the newborn nursery with exclusive breastfeeding after implementation of this protocol.

Maturational Characteristics of the Host Response to Group B Streptococcus Intestinal Colonization

By Luis De Bernardis, Nermeen Kidwai, and Jonathan Slimovitch (2019)

Group B streptococcus (GBS) is a leading cause of infectious morbidity during infancy. Maternal rectovaginal colonization serves as the major reservoir for GBS and transmission to the newborn typically occurs in the perinatal or early postnatal periods. The widespread implementation of intrapartum antibiotic prophylaxis of GBS-colonized mothers has drastically reduced the incidence of early onset infection (occurring in the first week of life). However, the incidence of late onset (LO) infection (more than 7 days of age) remains unchanged, and it is now the most common manifestation of invasive GBS disease in the United States and other regions of the world that have adopted similar intrapartum prophylaxis strategies.

Postnatal Growth Trajectory and Neurodevelopmental Outcomes in Preterm Neonates

By Elizabeth Scott, Bryn Seltzer, and Mirella Torresan (2019)

Extrauterine growth restriction remains common in preterm infants and may affect neurodevelopmental outcomes. The objective of this study is to look for an association between postnatal growth trajectory and neurodevelopmental outcomes at 18 to 24 months corrected gestational age in preterm infants born at less than 32 weeks gestation. The hypothesis is that infants with poor growth trajectories, as determined by lower z-score slopes, will have worse neurodevelopmental outcomes when compared to those with normal or high z-score slopes.

A Single Center's Experience with the Seventh Edition Neonatal Resuscitation Program Recommendations for Meconium-Stained Amniotic Fluid

By Destini Goodly and Halle Paredes (2018)

The study objective was to investigate whether there was a change in incidence and severity of meconium aspiration syndrome at the institution after the implementation of the seventh edition Neonatal Resuscitation Program (NRP) recommendations. The research team hypothesized that the rate of neonatal intensive care unit admissions and severity of disease for infants born through meconium stained amniotic fluid will be unchanged after the implementation of the seventh edition NRP recommendations.

Retrospective Criteria for Cannulation in a New Pediatric Extracorporeal Membrane Oxygenation Program

By Michael Kitchin and Margaret Zhang (2018)

NYU Langone’s Pediatric Extracorporeal Membrane Oxygenation (ECMO) Program started in March 2015 and since then has been consulted on nearly 70 patients and provided ECMO care to nearly 20 patients. This study looked at all of the consulted patients to see what differences exist between those who received ECMO and those who did not. The research team looked for differences in historically used physiologic criteria, echocardiogram parameters, and medication use. The hypothesis was that the PaO2 and O2 saturations would be lower, and the oxygenation index would be higher, in the patients who received ECMO than in those who did not.

The Effect of Donor Breast Milk on Postnatal Growth and Metabolic Bone Disease in Premature Infants

By Shanice Boyce and Kara Jordon (2018)

Donor breast milk is a valuable asset for preterm infants when mother's milk is contraindicated or unavailable. However, donor breast milk is pasteurized and loses calcium and phosphorus, among other nutrients, during that process. The study objectives were to determine whether donor breast milk had an effect on bone mineralization, growth, and neonatal comorbidities in preterm infants. The research team hypothesized that preterm infants who received donor breast milk would have an increased prevalence of metabolic bone disease and decreased postnatal growth.

Neurodevelopment Outcomes of Very Preterm and Extremely Preterm Infants

By Nicholas Santaniello and Paige William (2017)

Scholars used data collected at NYU Langone’s Neonatal Comprehensive Care Program follow-up clinic to assess neurodevelopment at 6, 12, 18, and 24 months in the sample population. The Bayley Scales of Infant and Toddler Development III to was used specifically get a better understanding of the correlation between gestational age and the cognitive, motor, and language development in this cohort. The secondary outcomes that may have affected neurodevelopment (e.g., intraventricular hemorrhage, periventricular leukomalacia, and retinopathy of prematurity) were also analyzed.

The Impact of Antenatal Corticosteroids on Neonatal Morbidities in Late Preterm and Early Term Neonates

By Julia Katz, Rebecca Trillo, and Kiran Bhutada (2017)

Preterm infants are at a greater risk than term infants for neonatal complications such as low birth weight, respiratory distress, and hypoglycemia. For many years, the American College of Obstetrics and Gynecology (ACOG) has recommended the administration of antenatal corticosteroids (ACS) to women at risk of birth before 34 weeks gestation in order to prevent respiratory morbidities. In June 2016, the ACOG changed the guidelines to also include the administration of ACS to women at risk of late preterm birth (34 to 37 weeks gestation). Recent studies have shown that early term infants (37 to 38 weeks gestation) may also benefit from ACS. This study looked at the effects of ACS administration on the incidence of respiratory morbidities in late preterm and early term infants born at NYU Langone between June 2015 and June 2017.

Group B Streptococcus Serotype Distribution Among Colonized Women

By Margaret Gegick and Evan Suzman (2017)

Maternal group B Streptococcus (GBS) colonization is the major risk factor for invasive neonatal disease. Maternal immunization against GBS represents an appealing strategy for disease prevention. Current vaccine candidates are serotype specific; therefore, it is critical to understand the distribution of GBS serotypes globally. The objectives of this study were to determine the prevalence of each of the 10 GBS serotypes in geographically distinct populations (New York City; and Gaborone and Ramotswa in Botswana) using real-time polymerase chain reaction (PCR) methodology and to determine the percentage of women colonized with multiple serotypes.